TIA1

Across TCGA pan-cancer cohorts, TIA1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of TIA1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where TIA1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TIA1 is over-expressed in tumor.

LUAD, LSCC, and HNSC are the cancer types where TIA1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TIA1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	III,IV	+0.570	<.001	9	view →
LSCC	Male	All	+0.588	<.001	8	view →
HNSC	Male	IV	+0.386	<.001	8	view →
COAD	Female	III,IV	+0.352	<.001	8	view →
PDAC	Male	All	+0.411	<.001	6	view →
CCRCC	Male	All	+0.269	<.001	6	view →
OV	All	All	+0.755	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

TIA1–LUAD

Open the LUAD breakdown →